alberto ravaioli

[alberto ravaioli @RavaioliAlberto]

Lorlatinib in Tyrosine Kinase Inhibitor−Naive Advanced ROS1-Positive Non−Small Cell Lung Cancer https://t.co/pPN0FSKOfL

[alberto ravaioli @RavaioliAlberto]

https://t.co/Te9VdiVU13

[alberto ravaioli @RavaioliAlberto]

https://t.co/kyQTsM7ztF

[alberto ravaioli @RavaioliAlberto]

https://t.co/H8ZatLnjLQ

[alberto ravaioli @RavaioliAlberto]

Medici espatriati: una mappa mondiale delle motivazioni e delle destinazioni https://t.co/LvXql2u0Ag

[alberto ravaioli @RavaioliAlberto]

https://t.co/1Bkl3XfaXR Orforglipron arriverà' nel 2026 pillola

[alberto ravaioli @RavaioliAlberto]

https://t.co/iQSw4GI0jd Da confermare

[alberto ravaioli @RavaioliAlberto]

https://t.co/OrhINZlikm Speriamo arrivi presto

[alberto ravaioli @RavaioliAlberto]

https://t.co/Om0I3oTtTu

[alberto ravaioli @RavaioliAlberto]

Quizartinib plus chemotherapy in newly diagnosed patients with FLT3-internal-tandem-duplication-positive acute myeloid leukaemia (QuANTUM-First): a randomised, double-blind, placebo-controlled, phase 3 trial - The Lancet https://t.co/RqFQKQErhw LMA

[alberto ravaioli @RavaioliAlberto]

Efficacy and Safety of Long-Term Continuous Nirogacestat Treatment in Adults With Desmoid Tumors: Results From the DeFi Trial | Journal of Clinical Oncology https://t.co/LMwx8FYic4

[alberto ravaioli @RavaioliAlberto]

https://t.co/yEMefSsgPZ

[alberto ravaioli @RavaioliAlberto]

https://t.co/H8ZatLnjLQ Non troppi pero'

[alberto ravaioli @RavaioliAlberto]

Proton Craniospinal Irradiation for Patients With Leptomeningeal Metastasis https://t.co/cEZZ1wrVQO

[alberto ravaioli @RavaioliAlberto]

'Tumori del colon-retto a esordio precoce: cresce il peso degli alimenti ultra-processati https://t.co/ZcgulpbkDs'

[alberto ravaioli @RavaioliAlberto]

'Dalle uova in frigo all’igiene delle spugnette, gli errori più comuni nelle cucine degli italiani https://t.co/H5LP8cp2gs'

[alberto ravaioli @RavaioliAlberto]

'Fibrillazione atriale, una tazzina di caffè al giorno la riduce. Lo dice la scienza https://t.co/4FTUhKmH3Q'

[alberto ravaioli @RavaioliAlberto]

Rhapsido Approved for Adults With Chronic Spontaneous Urticaria https://t.co/unwO4d5CCK

[alberto ravaioli @RavaioliAlberto]

Gazyva Approved for Adults With Active Lupus Nephritis https://t.co/HjFOWzeYgf

[alberto ravaioli @RavaioliAlberto]

Tezspire Gains Approval for Chronic Rhinosinusitis With Nasal Polyps https://t.co/4Otj8aHYkC